SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-15-029704
Filing Date
2015-04-23
Accepted
2015-04-23 16:06:07
Documents
4
Effectiveness Date
2015-04-23

Document Format Files

Seq Description Document Type Size
1 DEFA14A a15-8833_3defa14a.htm DEFA14A 35395
2 GRAPHIC g88333bci001.gif GRAPHIC 40298
3 GRAPHIC g88333bci002.gif GRAPHIC 63718
4 GRAPHIC g88333bci003.gif GRAPHIC 16610
  Complete submission text file 0001104659-15-029704.txt   203021
Mailing Address 1 LANDMARK SQUARE, SUITE 1122 STAMFORD CT 06901
Business Address 1 LANDMARK SQUARE, SUITE 1122 STAMFORD CT 06901 203-658-4749
Loxo Oncology, Inc. (Filer) CIK: 0001581720 (see all company filings)

IRS No.: 462996673 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36562 | Film No.: 15788507
SIC: 2834 Pharmaceutical Preparations